Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daneman

Showing results (711-720 of 849) with videos related to

Pageof 85
Sort By:
BMJ Open|May 14, 2020
Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) randomised clinical trial: study protocolNick Daneman, Asgar H Rishu, Ruxandra L Pinto, et al.
Plos One|July 24, 2008
Antimalarial therapy selection for quinolone resistance among Escherichia coli in the absence of quinolone exposure, in tropical South AmericaRoss J Davidson, Ian Davis, Barbara M Willey, et al.
Cell Reports|November 2, 2017
Evolutionarily Conserved Roles for Blood-Brain Barrier Xenobiotic Transporters in Endogenous Steroid Partitioning and BehaviorSamantha J Hindle, Roeben N Munji, Elena Dolghih, et al.
Journal of Clinical Microbiology|March 7, 2022
Prevalence and Mortality Associated with Bloodstream Organisms: a Population-Wide Retrospective Cohort StudyMark Verway, Kevin A Brown, Alex Marchand-Austin, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 18, 2022
Noninferiority Margin Size and Acceptance of Trial Results: Contingent Valuation Survey of Clinician Preferences for Noninferior MortalitySandra Pong, Robert A Fowler, Nicholas Mitsakakis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 3, 2026
Duration of therapy for Pseudomonas aeruginosa bacteremia - a post hoc subgroup analysis from the BALANCE randomized controlled trialDafna Yahav, Ruxandra Pinto, Deborah Cook, et al.
Jac-Antimicrobial Resistance|December 19, 2024
Leveraging local public health to advance antimicrobial stewardship (AMS) implementation and mitigate antimicrobial resistance (AMR): a scoping reviewValerie Leung, Diane Ashiru-Oredope, Lauri Hicks, et al.
Open Forum Infectious Diseases|November 19, 2019
Predictors of Treatment Failure for Hip and Knee Prosthetic Joint Infections in the Setting of 1- and 2-Stage Exchange Arthroplasty: A Multicenter Retrospective CohortChristopher E Kandel, Richard Jenkinson, Nick Daneman, et al.
Clinical Pediatrics|February 15, 2013
Pandemic management in a pediatric hospitalSavithiri Ratnapalan, Maria Athina Tina Martimianakis, Justine H Cohen-Silver, et al.
Plos One|July 26, 2022
Antibiotic treatment duration for bloodstream infections in critically ill children-A survey of pediatric infectious diseases and critical care clinicians for clinical equipoiseSandra Pong, Robert A Fowler, Srinivas Murthy, et al.
Pageof 85

Showing results (711-720 of 849) with videos related to

Sort By:
Pageof 85
BMJ Open|May 14, 2020
Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) randomised clinical trial: study protocolNick Daneman, Asgar H Rishu, Ruxandra L Pinto, et al.
Plos One|July 24, 2008
Antimalarial therapy selection for quinolone resistance among Escherichia coli in the absence of quinolone exposure, in tropical South AmericaRoss J Davidson, Ian Davis, Barbara M Willey, et al.
Cell Reports|November 2, 2017
Evolutionarily Conserved Roles for Blood-Brain Barrier Xenobiotic Transporters in Endogenous Steroid Partitioning and BehaviorSamantha J Hindle, Roeben N Munji, Elena Dolghih, et al.
Journal of Clinical Microbiology|March 7, 2022
Prevalence and Mortality Associated with Bloodstream Organisms: a Population-Wide Retrospective Cohort StudyMark Verway, Kevin A Brown, Alex Marchand-Austin, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 18, 2022
Noninferiority Margin Size and Acceptance of Trial Results: Contingent Valuation Survey of Clinician Preferences for Noninferior MortalitySandra Pong, Robert A Fowler, Nicholas Mitsakakis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 3, 2026
Duration of therapy for Pseudomonas aeruginosa bacteremia - a post hoc subgroup analysis from the BALANCE randomized controlled trialDafna Yahav, Ruxandra Pinto, Deborah Cook, et al.
Jac-Antimicrobial Resistance|December 19, 2024
Leveraging local public health to advance antimicrobial stewardship (AMS) implementation and mitigate antimicrobial resistance (AMR): a scoping reviewValerie Leung, Diane Ashiru-Oredope, Lauri Hicks, et al.
Open Forum Infectious Diseases|November 19, 2019
Predictors of Treatment Failure for Hip and Knee Prosthetic Joint Infections in the Setting of 1- and 2-Stage Exchange Arthroplasty: A Multicenter Retrospective CohortChristopher E Kandel, Richard Jenkinson, Nick Daneman, et al.
Clinical Pediatrics|February 15, 2013
Pandemic management in a pediatric hospitalSavithiri Ratnapalan, Maria Athina Tina Martimianakis, Justine H Cohen-Silver, et al.
Plos One|July 26, 2022
Antibiotic treatment duration for bloodstream infections in critically ill children-A survey of pediatric infectious diseases and critical care clinicians for clinical equipoiseSandra Pong, Robert A Fowler, Srinivas Murthy, et al.
Pageof 85